[Pharmacogenetics and tailored drug therapy]

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

[Pharmacogenetics and tailored drug therapy]. / Nielsen, F.C.; Borregaard, N.

I: Ugeskrift for læger, Bind 171, Nr. 10, 2009, s. 790-794.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Nielsen, FC & Borregaard, N 2009, '[Pharmacogenetics and tailored drug therapy]', Ugeskrift for læger, bind 171, nr. 10, s. 790-794.

APA

Nielsen, F. C., & Borregaard, N. (2009). [Pharmacogenetics and tailored drug therapy]. Ugeskrift for læger, 171(10), 790-794.

Vancouver

Nielsen FC, Borregaard N. [Pharmacogenetics and tailored drug therapy]. Ugeskrift for læger. 2009;171(10):790-794.

Author

Nielsen, F.C. ; Borregaard, N. / [Pharmacogenetics and tailored drug therapy]. I: Ugeskrift for læger. 2009 ; Bind 171, Nr. 10. s. 790-794.

Bibtex

@article{70ac6320626c11df928f000ea68e967b,
title = "[Pharmacogenetics and tailored drug therapy]",
abstract = "Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology Udgivelsesdato: 2009/3/2",
author = "F.C. Nielsen and N. Borregaard",
note = "Cochrane: Statusart., ok. Vi har downloadet denne reference igen, da afd. har downloadet ref. med forkert filter. Cochrane: Den danske tekst klippet hertil, Farmakogenetik og skr{\ae}ddersyet medicinsk behandling, og den downloadede engelske tekst sat i titel.",
year = "2009",
language = "Dansk",
volume = "171",
pages = "790--794",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "10",

}

RIS

TY - JOUR

T1 - [Pharmacogenetics and tailored drug therapy]

AU - Nielsen, F.C.

AU - Borregaard, N.

N1 - Cochrane: Statusart., ok. Vi har downloadet denne reference igen, da afd. har downloadet ref. med forkert filter. Cochrane: Den danske tekst klippet hertil, Farmakogenetik og skræddersyet medicinsk behandling, og den downloadede engelske tekst sat i titel.

PY - 2009

Y1 - 2009

N2 - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology Udgivelsesdato: 2009/3/2

AB - Pharmacogenetics traditionally designates the study of genetically determined variation in metabolism of drugs and toxins from the environment. The concept of phamacogenetics has been widened to encompass how essential genetic alterations central to the development of diseases may by used to target medical treatment in a patient-tailored way. This paper highlights some of the novel developments in relation to oncology and haematology Udgivelsesdato: 2009/3/2

M3 - Tidsskriftartikel

VL - 171

SP - 790

EP - 794

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 10

ER -

ID: 19797762